Recormon Drug Interactions

epoetin beta




Zuellig Pharma
Full Prescribing Info
Drug Interactions
No dedicated clinical interaction studies have been performed.
Clinical experience has not given evidence for potential interaction of Recormon with other medicinal products (for more information see also Pharmacology: Toxicology: Nonclinical Safety: Other under Actions).
In animal experiments epoetin did not increase the myelotoxicity of cytostatic medicinal products like etoposide, cisplatin, cyclophosphamide and fluorouracil.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in